Nightingale Announces Redemption and Re-issuance of Convertible Debentures
14 Januar 2012 - 12:00AM
PR Newswire (Canada)
MARKHAM, ON, Jan. 13, 2012 /CNW/ - Nightingale Informatix
Corporation www.nightingalemd.com "Nightingale" or "Company", an
application service provider (ASP) of electronic medical record
(EMR) software and related services, today announced the redemption
of 133 of its existing 12% convertible unsecured subordinated
debentures at a price of $133,000 and the issuance, on a
non-brokered private placement basis, of 125 12% convertible
unsecured subordinated debentures (the "Debentures") under the same
terms, as a replacement, for total gross proceeds of $125,000. The
125 Debentures bear 12% interest calculated and payable in cash
monthly, and are scheduled to mature on January 15, 2016. The
Company has the right to redeem the Debentures, in whole or in
part, at a price equal to their principal amount plus accrued and
unpaid interest. The Debentures are convertible at the holder's
option into fully-paid common shares at any time prior to maturity
or redemption at a conversion price of $0.35 per share. About
Nightingale Informatix Corporation (www.nightingalemd.com)
Nightingale is one of the fastest growing health care service and
software companies in North America and is recognized as an
industry leader in Web-based clinician and community based
electronic medical records (EMR) serving the needs of small primary
care practices, multi-physician outpatient clinics, and large scale
regional health organizations and networks. Coupled with integrated
practice management, transcription and revenue cycle management,
Nightingale's comprehensive service offering allows customers to
enhance patient care, increase revenue opportunities and optimize
operations. Nightingale is continuously innovating and enhancing
its services to meet the needs of its growing and diverse customer
base. Nightingale - Health care
connected. www.nightingalemd.com Forward-Looking Statement
This press release contains "forward-looking statements" respecting
the issuance and cancellation of securities of the Company within
the meaning of applicable Canadian securities legislation.
Generally, forward-looking statements can be identified by the use
of forward- looking terminology such as "plans", "expects" or "does
not expect", "is expected", "budget", "scheduled", "estimates",
"forecasts", "intends", "anticipates" or "does not anticipate", or
"believes", or variations of such words and phrases or state that
certain actions, events or results "may" ,"could", "would", "might"
or "will be taken", "occur" or "be achieved". Forward-looking
statements are subject to known and unknown risks, uncertainties
and other factors that may cause the actual results, level of
activity, performance or achievements of Nightingale to be
materially different from those expressed or implied by such
forward-looking statements, including but not limited to: risks
related to the speculative nature of the medical software industry,
which is affected by numerous factors beyond Nightingale's control;
the ability of Nightingale to successfully integrate its
acquisitions and any liabilities arising as a result of such
acquisitions, access to capital and agreements with its Lenders;
the existence of present and possible future government regulation;
access to debt or equity financing and agreements with its Lenders;
the significant and increasing competition that exists in the
medical software industry; the early stage of Nightingale's
business; and therefore it is subject to the risks associated with
early stage companies, including uncertainty of revenues, markets
and profitability and the need to raise additional funding.
All material assumptions used in making forward-looking statements
are based on management's knowledge of current business conditions
and expectations of future business conditions and trends. Although
management believes the assumptions used to make such statements
are reasonable at this time, our assumptions may not to be as
anticipated, estimated or intended. Certain material factors or
assumptions applied by management in making forward-looking
statements, include without limitation, factors and assumptions
regarding Nightingale's continued ability to fund its business,
rates of customer defaults, relationships with, and payments to,
lenders, demand for Nightingale's products, as well as
Nightingale's operating cost structure. Although Nightingale has
attempted to identify important factors that could cause actual
results to differ materially from those contained in
forward-looking statements, there may be other factors that cause
results not to be as anticipated, estimated or intended. There can
be no assurance that such statements will prove to be accurate, as
actual results and future events could differ materially from those
anticipated in such statements. Accordingly, readers should not
place undue reliance on forward-looking statements. Nightingale
does not undertake to update any forward-looking statements that
are incorporated by reference herein, except in accordance with
applicable securities laws. Further information on Nightingale
Informatix Corporation is available at www.sedar.com. Neither the
TSX Venture Exchange nor its Regulation Services Provider (as that
term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this
release. Nightingale Informatix Corporation CONTACT: Investor
InquiriesMichael Ford Kristen Dickson, M.Sc.CFO, Nightingale
Informatix TMX EquicomCorporation Tel: 416.815.0700 ext. 273Tel:
905.307.7870 kdickson@equicomgroup.commford@nightingalemd.com
Copyright
Nightingale Informatix Corporati (TSXV:NGH)
Historical Stock Chart
Von Jun 2024 bis Jul 2024
Nightingale Informatix Corporati (TSXV:NGH)
Historical Stock Chart
Von Jul 2023 bis Jul 2024